证券代码：002016 证券简称：世荣兆业 公告编号：2025-050 广东世荣兆业股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案； 2、本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 本次股东大会以现场表决和网络投票表决相结合的方式审议并通过如下议案： 1、《关于修订<公司章程>及其附件的议案》 1.01《关于修订<公司章程>的议案》 同意 495,238,394 股，占出席本次股东大会有效表决权股份总数的 99.9826%； 反对 76,300 股，占出席本次股东大会有效表决权股份总数的 0.0154%；弃权 10,100 股，占出席本次股东大会有效表决权股份总数的 0.0020%。 本议案为特别决议事项，已获得出席本次股东大会有效表决权股份总数的 2/3 以上通过。 广东世荣兆业股份有限公司（以下简称"公司"、"本公司"）2025 年第一次临 时股东大会于 2025 年 10 月 31 日下午 2:30 在公司五楼会议室召开。本次股 ...

炜衡律师事务所/珠海 W&H LAW FIRM/ZHUHAI 北京市炜衡（珠海）律师事务所 关于广东世荣兆业股份有限公司 召开 2025 年第一次临时股东大会的法律意见书 致：广东世荣兆业股份有限公司 炜衡律师事务所/珠海 W&H LAW FIRM/ZHUHAI 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人 民共和国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上 市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规和其他有 关规范性文件的要求，北京市炜衡（珠海）律师事务所（以下简称"本所"） 接受广东世荣兆业股份有限公司（以下简称"公司"）的委托，指派律师林建 辉、张家华参加公司 2025 年第一次临时股东大会（以下简称"本次股东大会"）。 本所声明：本所律师仅对本次股东大会的召集程序、召开程序、出席会议人 员资格、召集人资格、表决程序及表决结果发表法律意见，并不对本次股东大会 所审议的议案、议案所涉及的数字及内容发表意见。本所律师同意将本法律意见 书随本次股东大会其他信息披露资料一并公告。 本法律意见书仅供见证公司本次股东大会相关事项的合法性之目的使用， 不得用作 ...

Core Insights - The stock price of Shiyong Zhaoye increased by 2.01% on October 31, reaching 6.61 CNY per share, with a total market capitalization of 5.348 billion CNY [1] - The company has seen a year-to-date stock price increase of 7.13%, with significant gains over the past 5, 20, and 60 trading days [1] - Shiyong Zhaoye reported a substantial increase in revenue and net profit for the first nine months of 2025, with revenue growing by 65.17% and net profit increasing by 418.51% year-on-year [2] Financial Performance - For the period from January to September 2025, Shiyong Zhaoye achieved operating revenue of 1.191 billion CNY and a net profit attributable to shareholders of 124 million CNY [2] - The company has distributed a total of 1.888 billion CNY in dividends since its A-share listing, with 48.5457 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 9.49% to 18,200, while the average number of circulating shares per person increased by 10.48% to 44,472 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI Real Estate ETF, both of which have reduced their holdings compared to the previous period [3]

Market Overview - The Shanghai Composite Index closed at 4001.98 points, above the five-day moving average, with a gain of 0.35% [1] - The total trading volume of A-shares reached 183.41 billion yuan [1] Stocks Performance - A total of 484 A-shares have surpassed the five-day moving average today [1] - Notable stocks with significant deviation rates include: - Digital People (11.77%) - Sanxiang Technology (10.45%) - Jinhua New Materials (9.20%) [1] Top Stocks by Deviation Rate - Digital People: - Today's price increase: 15.20% - Turnover rate: 16.90% - Latest price: 16.37 yuan [1] - Sanxiang Technology: - Today's price increase: 13.27% - Turnover rate: 10.72% - Latest price: 21.76 yuan [1] - Jinhua New Materials: - Today's price increase: 12.75% - Turnover rate: 23.32% - Latest price: 54.57 yuan [1] Additional Notable Stocks - Kangzhi Pharmaceutical: - Today's price increase: 14.37% - Turnover rate: 30.60% - Latest price: 7.96 yuan [1] - Huaxin Yongdao: - Today's price increase: 12.00% - Turnover rate: 8.41% - Latest price: 44.91 yuan [1] - Longi Green Energy: - Today's price increase: 10.00% - Turnover rate: 5.01% - Latest price: 20.79 yuan [1]

Core Points - The Shanghai Composite Index is at 3994.82 points, above the five-day moving average, with a slight increase of 0.17% [1] - The total trading volume of A-shares today is 10539.94 billion yuan, with 290 A-shares breaking through the five-day moving average [1] Summary by Category Stock Performance - Notable stocks with significant deviation rates above the five-day moving average include: - Digital Human (证券代: 920670) with a price increase of 15.55% and a deviation rate of 12.04% [1] - Sanxiang Technology (证券代: 920195) with a price increase of 14.32% and a deviation rate of 11.23% [1] - Kangzhi Pharmaceutical (证券代: 300086) with a price increase of 14.80% and a deviation rate of 9.06% [1] Trading Activity - The trading turnover rates for the top stocks include: - Digital Human at 10.89% [1] - Sanxiang Technology at 8.85% [1] - Kangzhi Pharmaceutical at 26.97% [1] Additional Stocks - Other stocks with notable performance include: - Fulongma (证券代: 603686) with a price increase of 9.98% and a deviation rate of 8.13% [1] - Sifang Holdings (证券代: 601126) with a price increase of 10.01% and a deviation rate of 7.47% [1] - Yuanda Intelligence (证券代: 002689) with a price increase of 10.07% and a deviation rate of 7.42% [1]

Market Overview - The three major indices opened higher, with the Shanghai Composite Index at 3990.27 points, up 0.05%, the Shenzhen Component Index at 13484.01 points, up 0.40%, and the ChiNext Index at 3263.98 points, up 1.07% [1] Policy and Economic Development - The Central Committee of the Communist Party of China published suggestions for the 15th Five-Year Plan, emphasizing the cultivation of emerging industries and strategic sectors such as new energy, new materials, aerospace, and quantum technology [1] - The People's Bank of China reported on financial work, highlighting the need to prevent systemic financial risks and to strengthen the capital market [1] Industry Performance - The 11th batch of national drug centralized procurement included 55 commonly used drugs across various fields, indicating ongoing efforts in healthcare cost management [2] - Ganfeng Lithium reported a 364% year-on-year increase in net profit for Q3, driven by expanded sales [2] - Zhonghang Chengfei announced a net profit of 1.256 billion yuan for Q3, up 169.53% year-on-year [2] - Zhaoyi Innovation reported a net profit of 508 million yuan for Q3, a 61.13% increase year-on-year [2] - Huasheng Tiancai's Q3 net profit surged by 563.58% to 219 million yuan [2] - China Film's Q3 net profit reached 177 million yuan, up 1,463.17% year-on-year [2] - Shengyi Technology reported a net profit of 1.115 billion yuan for the first three quarters, a 498% increase [2] - Sungrow Power reported a net profit of 4.147 billion yuan for the first three quarters, up 57.04% year-on-year [2] - Huitian Technology announced a net profit of 2.718 billion yuan for the first three quarters, a 47.03% increase, benefiting from structural demand in AI [2] Corporate Developments - Lianqi Technology announced that its shareholders' combined stake fell below 5% [3] - Delong Huineng announced a change in its controlling shareholder and actual controller, leading to stock resumption [3] - Dahua Intelligent stated that it currently has no business related to quantum technology [4] International Market Trends - The U.S. Senate rejected a temporary funding bill, leading to a continued government shutdown [5] - U.S. stock indices collectively rose, with the Nasdaq up 0.8%, Dow Jones up 0.34%, and S&P 500 up 0.23% [5] - Nvidia's stock rose approximately 5%, nearing a market capitalization of $5 trillion [5] Technological Advancements - Eli Lilly announced the deployment of the world's largest and most powerful AI pharmaceutical factory, utilizing Nvidia's DGX supercluster [6] - Nvidia plans to ship 20 million Blackwell and Rubin GPUs, expecting a business scale of $500 billion over the next six quarters [7] - OpenAI reported a total investment of approximately $1.4 trillion for AI infrastructure construction [8] - Microsoft and OpenAI signed a new agreement to support OpenAI's capital restructuring, with Microsoft acquiring about 27% equity in OpenAI [8] - The U.S. Department of Energy announced collaborations with Nvidia and Oracle to build seven new AI supercomputers [9]

Core Viewpoint - The company reported significant financial changes in its third-quarter report, highlighting substantial increases in revenue and net profit, alongside various shifts in asset and liability accounts [3][4][5][6][19]. Financial Performance - Cash and cash equivalents increased by 200.48% compared to the end of the previous year, primarily due to increased bank loans and collections from property sales [4]. - Revenue and operating costs for the year-to-date increased by 65.17% and 96.14% respectively, attributed to higher sales of transferable residential properties [5]. - Net profit attributable to the parent company rose by 418.51% year-on-year, driven by increased operating profit [5][19]. Asset and Liability Changes - Accounts receivable decreased by 98.92%, mainly due to a reduction in bank acceptance bills [5]. - Contract assets increased by 103.90%, reflecting a rise in landscaping construction contract settlements [5]. - Long-term borrowings surged by 236.59%, indicating a significant increase in bank loans over one year [5]. Expenses and Profitability - Sales expenses rose by 147.60%, primarily due to increased sales agency fees [6]. - Management expenses decreased by 43.69%, attributed to reduced detailed expenditures [7]. - Financial expenses increased by 168.10%, mainly due to higher interest expenses [9]. Cash Flow - Net cash flow from operating activities increased by 102.15%, driven by higher collections from real estate sales [21]. - Net cash flow from investing activities rose by 54.32%, due to reduced investments in construction projects [21]. - Net cash flow from financing activities increased by 135.32%, reflecting higher cash inflows from bank loans [21]. Shareholder Information - The company is undergoing a significant change in its shareholder structure, with a transfer of control from Zhuhai Dahongqiao Group to Zhuhai Zhuguang Group, which will indirectly hold 60.28% of the company's shares [10][11]. Legal Matters - The company is involved in ongoing litigation to recover damages from former chairman Liang Jiarong, with a court ruling in favor of the company for $258.54 million [12]. - The company has also initiated legal proceedings against a partner for contract disputes, resulting in a favorable judgment for the return of 65 million yuan [13].

Core Viewpoint - The company reported significant growth in both revenue and net profit for the third quarter of 2025, indicating strong operational performance and financial health [1] Financial Performance - In Q3 2025, the company achieved a revenue of 593 million yuan, representing a year-on-year increase of 235.68% [1] - The net profit attributable to shareholders for Q3 2025 was 109 million yuan, showing a remarkable year-on-year growth of 3168.80% [1] - Basic earnings per share for Q3 2025 stood at 0.1344 yuan [1] - For the first three quarters of 2025, the company reported a total revenue of 1.191 billion yuan, which is a year-on-year increase of 65.17% [1] - The net profit attributable to shareholders for the first three quarters was 124 million yuan, reflecting a year-on-year growth of 418.51% [1] - Basic earnings per share for the first three quarters was 0.1533 yuan [1]

Core Viewpoint - The company reported significant growth in both revenue and net profit for the third quarter, indicating strong operational performance and financial health [1] Financial Performance - The company's revenue for the first three quarters reached 1.19 billion, representing a year-on-year increase of 65.17% [1] - The net profit attributable to shareholders for the same period was 124 million, showing a remarkable year-on-year growth of 418.51% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 123 million, reflecting a substantial year-on-year increase of 439.78% [1]

表决结果：3 票同意，0 票反对，0 票弃权。 证券代码：002016 证券简称：世荣兆业 公告编号：2025-049 广东世荣兆业股份有限公司 第八届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 广东世荣兆业股份有限公司（以下简称"公司"）第八届监事会第十六次会 议通知于 2025 年 10 月 22 日分别以书面和电子邮件形式发出，会议于 2025 年 10 月 28 日以通讯表决方式召开。本次会议应出席监事 3 名，实际出席监事 3 名。 会议的召开符合《公司法》和《公司章程》的有关规定。 与会监事经审议，以记名投票的方式形成如下决议： 一、审议并通过《2025 年第三季度报告》 经审核，监事会认为董事会编制和审核广东世荣兆业股份有限公司 2025 年 第三季度报告的程序符合法律、行政法规和中国证监会的规定，报告内容真实、 准确、完整地反映了上市公司的实际情况，不存在任何虚假记载、误导性陈述或 者重大遗漏。 《2025 年第三季度报告》于 2025 年 10 月 29 日披露于《中国证券报》、《证 券时报》、《证券日报》、《 ...